A Frier Levitt pharmacist-attorney has been interviewed on a Talk to Your Pharmacist podcast episode titled, “Regulatory Considerations in Compounding Pharmacy Practice.” This comprehensive discussion focuses on the current regulatory landscape for compounding pharmacies. Insights include:
- The Current Regulatory Environment for 503A and 503B Compounding
- 2023/2024 State Laws and State Board of Pharmacy
- Key Regulatory Considerations in the 503B to 503A Compounding Model for Community Pharmacies
- 506e Shortages and Beyond
- USP 797/795 Six Months Later
